2.50
+0.81%
Close of 9 Nov 2026, in THB
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Asian Phytoceuticals PCL
Its shares trade on SET under the ticker APCO.BK. It has been listed since 4 November 2011. In the fiscal year to 31 December 2025, it reported revenue of THB 200.2m and net income of THB 55.4m. At that date it held total assets of THB 631.1m and shareholders' equity of THB 557.0m.
Asian Phytoceuticals Public Co., Ltd. engages in the research and development, manufacture, and distribution of health and beauty products from natural extracts. The company is headquartered in Lamphun, Lamphun. The company went IPO on 2011-11-04. The company operates through the manufacturing and distribution of dietary supplements from herbs. The Company’s products and brands include operation balancing immunity (BIM), longevity, and slimming and beauty products. Its operation BIM includes Mylife, LIV Capsule, Garcinia, Arthrinox, Diabenok, Tumorid capsule, Noriasis, Canvirol and others. The Company’s slimming products include Asian Life Revitalizing Serum, Asian Life Revitalizing Cream, Garcinia Acne Cream, Garcinia Facial Cleansing Gel, Garcinia Cleansing Cream, Noriasis Nourishing Skin Cream, and others. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Care Products
- Listed since
- 4 Nov 2011
- Employees
- 99
- Website
- apco.co.th/en/home ↗
Leadership
Pay as last reported
- Ms. Maleeratna PlumchitchomNon-Executive Independent Chairman of the Board, since 2011THB 283,219
- Prof. Dr. Pichaet WiriyachitraChief Executive Officer, Executive Director, since 2016
- Ms. Apinya UlumpanonChief Financial Officer, Assistant to Chief Executive Officer - Accounting and Finance
- Mr. Sakda SreesangkomChief Operating Officer
- Mrs. Jannatthabhorn JanprasertAssistant to Chief Executive Officer - Production
- Ms. Ornphimol PrasertwitAssistant to Chief Executive Officer - Marketing, since 2015
- Ms. Sureeporn TeeyaprechayaAssistant to Chief Executive Officer - Management, since 2021
- Mrs. Sirithip WiriyachitraAssistant to Chief Executive Officer - Research and Quality Assurance
- Assoc. Prof. Arunee WiriyachitraCompany Secretary, Non-Executive Director
- Dr. Jingjai HanchanlashNon-Executive Director, since 2005THB 75,000
- Prof. Dr. Praipol KoomsupNon-Executive Independent DirectorTHB 238,219
- Assoc. Prof. Dr. Varakorn SamakosesNon-Executive Independent Director, since 2015THB 238,219
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Asian Phytoceuticals PCL operates in the Consumer Staples sector with 99 employees and a strong focus on natural health products.
- The company's product portfolio includes BIM, longevity, and slimming brands with multiple herbal supplement offerings.
- Killer T Cell for Pets Co., Ltd. expands the company's reach into the global animal market for pharmaceutical supplements.
Weaknesses
- The company has only 99 employees, which may limit its operational capacity and scalability.
- Asian Phytoceuticals PCL is listed on the Thai stock market with a 2011 IPO date, indicating limited market presence.
- The company's product range is heavily focused on herbal supplements without diversification into other consumer segments.
Opportunities
- The growing global demand for natural health and beauty products presents a significant market opportunity.
- Expanding the Killer T Cell for Pets Co., Ltd. subsidiary into new international markets could increase revenue streams.
- The company can leverage its existing BIM product line to enter new geographic markets within Asia.
Threats
- Competition from larger pharmaceutical companies in the health and beauty sector could impact market share.
- Regulatory changes in the Thai market may affect the production and distribution of herbal supplements.
- Economic downturns in Thailand could reduce consumer spending on non-essential health and beauty products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.